Indication,ComplexityScore,Category,ProjectedMonetaryValue,TextDescription
Chronic Low Back Pain,62,Pain/Inflammation,8.0,Chronic Low Back Pain is a common condition that is highly complex involving overlapping neural and inflammatory pathways and has a substantial market opportunity given the number of patients affected.
Neuropathic Pain,47,Pain/Inflammation,4.0,Neuropathic Pain is a disease with moderate complexity involving overlapping neural and inflammatory pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Osteoarthritis,50,Pain/Inflammation,10.0,Osteoarthritis is a very common condition that is moderately complex involving overlapping neural and inflammatory pathways and has a very large market potential due to its high prevalence and unmet needs.
Migraine,45,Pain/Inflammation,5.0,Migraine is a common condition with moderate complexity involving overlapping neural and inflammatory pathways and has a substantial market opportunity given the number of patients affected.
Fibromyalgia,36,Pain/Inflammation,2.0,Fibromyalgia is a disease with relatively straightforward underlying biology and presents a moderate market opportunity as a niche area in need of better treatments.
Gout,50,Pain/Inflammation,3.0,Gout is a disease with moderate complexity involving overlapping neural and inflammatory pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Endometriosis,64,Pain/Inflammation,2.0,Endometriosis is a common condition that is highly complex involving overlapping neural and inflammatory pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Post-operative Pain,51,Pain/Inflammation,4.0,Post-operative Pain is a disease with moderate complexity involving overlapping neural and inflammatory pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Diabetic Neuropathy,42,Pain/Inflammation,2.0,Diabetic Neuropathy is a disease with moderate complexity involving overlapping neural and inflammatory pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Postherpetic Neuralgia,53,Pain/Inflammation,2.0,Postherpetic Neuralgia is a disease with moderate complexity involving overlapping neural and inflammatory pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Trigeminal Neuralgia,40,Pain/Inflammation,2.0,Trigeminal Neuralgia is a disease with moderate complexity involving overlapping neural and inflammatory pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Cancer Pain,59,Pain/Inflammation,5.0,Cancer Pain is a disease with moderate complexity involving overlapping neural and inflammatory pathways and has a substantial market opportunity given the number of patients affected.
Cluster Headache,61,Pain/Inflammation,1.0,Cluster Headache is a disease that is highly complex involving overlapping neural and inflammatory pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Interstitial Cystitis,36,Pain/Inflammation,0.5,Interstitial Cystitis is a rare disorder with relatively straightforward underlying biology and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Complex Regional Pain Syndrome (CRPS),48,Pain/Inflammation,0.5,Complex Regional Pain Syndrome (CRPS) is a disease with moderate complexity involving overlapping neural and inflammatory pathways and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Primary Dysmenorrhea,44,Pain/Inflammation,1.0,Primary Dysmenorrhea is a disease with moderate complexity involving overlapping neural and inflammatory pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Temporomandibular Joint Disorder (TMJ),61,Pain/Inflammation,0.2,Temporomandibular Joint Disorder (TMJ) is a disease that is highly complex involving overlapping neural and inflammatory pathways and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Phantom Limb Pain,58,Pain/Inflammation,0.5,Phantom Limb Pain is a disease that is highly complex involving overlapping neural and inflammatory pathways and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Non-small cell lung cancer,80,Cancer,15.0,Non-small cell lung cancer is a very common condition that is extremely complex with many genetic mutations and cellular pathways involved and has a very large market potential due to its high prevalence and unmet needs.
Small cell lung cancer,77,Cancer,5.0,Small cell lung cancer is a common condition that is highly complex with many genetic mutations and cellular pathways involved and has a substantial market opportunity given the number of patients affected.
Breast cancer,87,Cancer,15.0,Breast cancer is a very common condition that is extremely complex with many genetic mutations and cellular pathways involved and has a very large market potential due to its high prevalence and unmet needs.
Colorectal cancer,78,Cancer,12.0,Colorectal cancer is a very common condition that is highly complex with many genetic mutations and cellular pathways involved and has a very large market potential due to its high prevalence and unmet needs.
Prostate cancer,77,Cancer,10.0,Prostate cancer is a very common condition that is highly complex with many genetic mutations and cellular pathways involved and has a very large market potential due to its high prevalence and unmet needs.
Pancreatic cancer,89,Cancer,5.0,Pancreatic cancer is a disease that is extremely complex with many genetic mutations and cellular pathways involved and has a substantial market opportunity given the number of patients affected.
Ovarian cancer,86,Cancer,3.0,Ovarian cancer is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Gastric cancer,75,Cancer,2.0,Gastric cancer is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Liver cancer,79,Cancer,3.0,Liver cancer is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Esophageal cancer,77,Cancer,2.0,Esophageal cancer is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Renal cell carcinoma,74,Cancer,2.0,Renal cell carcinoma is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Bladder cancer,69,Cancer,2.0,Bladder cancer is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Melanoma,89,Cancer,5.0,Melanoma is a disease that is extremely complex with many genetic mutations and cellular pathways involved and has a substantial market opportunity given the number of patients affected.
Glioblastoma,93,Cancer,5.0,Glioblastoma is a disease that is extremely complex with many genetic mutations and cellular pathways involved and has a substantial market opportunity given the number of patients affected.
Head and Neck cancer,85,Cancer,3.0,Head and Neck cancer is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Cervical cancer,83,Cancer,3.0,Cervical cancer is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Endometrial cancer,73,Cancer,3.0,Endometrial cancer is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Acute Myeloid Leukemia,82,Cancer,3.0,Acute Myeloid Leukemia is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Acute Lymphoblastic Leukemia,71,Cancer,2.0,Acute Lymphoblastic Leukemia is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Chronic Myelogenous Leukemia,65,Cancer,2.0,Chronic Myelogenous Leukemia is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Chronic Lymphocytic Leukemia,68,Cancer,2.0,Chronic Lymphocytic Leukemia is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Non-Hodgkin Lymphoma,81,Cancer,2.0,Non-Hodgkin Lymphoma is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Hodgkin Lymphoma,66,Cancer,2.0,Hodgkin Lymphoma is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Multiple Myeloma,86,Cancer,3.0,Multiple Myeloma is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Neuroblastoma,83,Cancer,2.0,Neuroblastoma is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Soft Tissue Sarcoma,77,Cancer,2.0,Soft Tissue Sarcoma is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Osteosarcoma,81,Cancer,2.0,Osteosarcoma is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Cholangiocarcinoma,69,Cancer,2.0,Cholangiocarcinoma is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Thyroid cancer,74,Cancer,2.0,Thyroid cancer is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Medulloblastoma,84,Cancer,2.0,Medulloblastoma is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Uveal Melanoma,77,Cancer,2.0,Uveal Melanoma is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Mesothelioma,69,Cancer,2.0,Mesothelioma is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Waldenstrom Macroglobulinemia,85,Cancer,0.5,Waldenstrom Macroglobulinemia is a rare disorder that is extremely complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Mantle Cell Lymphoma,79,Cancer,0.5,Mantle Cell Lymphoma is a rare disorder that is highly complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Diffuse Large B-Cell Lymphoma,73,Cancer,1.0,Diffuse Large B-Cell Lymphoma is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Follicular Lymphoma,66,Cancer,0.5,Follicular Lymphoma is a disease that is highly complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Myelodysplastic Syndromes (MDS),85,Cancer,0.5,Myelodysplastic Syndromes (MDS) is a rare disorder that is extremely complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Myelofibrosis,77,Cancer,0.5,Myelofibrosis is a rare disorder that is highly complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Polycythemia Vera,71,Cancer,0.3,Polycythemia Vera is a rare disorder that is highly complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Essential Thrombocythemia,79,Cancer,0.3,Essential Thrombocythemia is a rare disorder that is extremely complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Ewing Sarcoma,86,Cancer,0.2,Ewing Sarcoma is a rare disorder that is extremely complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Rhabdomyosarcoma,85,Cancer,0.2,Rhabdomyosarcoma is a rare disorder that is extremely complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Wilms Tumor,78,Cancer,0.2,Wilms Tumor is a rare disorder that is highly complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Neuroendocrine Tumors (NETs),75,Cancer,3.0,Neuroendocrine Tumors (NETs) is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Diffuse Intrinsic Pontine Glioma (DIPG),93,Cancer,0.2,Diffuse Intrinsic Pontine Glioma (DIPG) is a rare disorder that is extremely complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Desmoid Tumors,67,Cancer,0.2,Desmoid Tumors is a rare disorder that is highly complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Retinoblastoma,77,Cancer,0.2,Retinoblastoma is a rare disorder that is highly complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Anaplastic Thyroid Carcinoma,82,Cancer,0.2,Anaplastic Thyroid Carcinoma is a rare disorder that is extremely complex with many genetic mutations and cellular pathways involved and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Basal Cell Carcinoma,81,Cancer,1.0,Basal Cell Carcinoma is a disease that is extremely complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Cutaneous Squamous Cell Carcinoma,70,Cancer,1.0,Cutaneous Squamous Cell Carcinoma is a disease that is highly complex with many genetic mutations and cellular pathways involved and presents a moderate market opportunity as a niche area in need of better treatments.
Acute Coronary Syndrome,61,Cardiovascular,5.0,Acute Coronary Syndrome is a very common condition that is highly complex involving multiple organ systems and risk factors and has a very large market potential due to its high prevalence and unmet needs.
Myocardial Infarction,66,Cardiovascular,5.0,Myocardial Infarction is a very common condition that is highly complex involving multiple organ systems and risk factors and has a very large market potential due to its high prevalence and unmet needs.
Heart Failure,71,Cardiovascular,10.0,Heart Failure is a very common condition that is highly complex involving multiple organ systems and risk factors and has a very large market potential due to its high prevalence and unmet needs.
Atrial Fibrillation,47,Cardiovascular,3.0,Atrial Fibrillation is a common condition with moderate complexity involving multiple organ systems and risk factors and presents a moderate market opportunity as a niche area in need of better treatments.
Ischemic Stroke,56,Cardiovascular,5.0,Ischemic Stroke is a very common condition with moderate complexity involving multiple organ systems and risk factors and has a very large market potential due to its high prevalence and unmet needs.
Hypertension,69,Cardiovascular,10.0,Hypertension is a very common condition that is highly complex involving multiple organ systems and risk factors and has a very large market potential due to its high prevalence and unmet needs.
Hyperlipidemia,47,Cardiovascular,8.0,Hyperlipidemia is a very common condition with moderate complexity involving multiple organ systems and risk factors and has a very large market potential due to its high prevalence and unmet needs.
Peripheral Arterial Disease,65,Cardiovascular,2.0,Peripheral Arterial Disease is a common condition that is highly complex involving multiple organ systems and risk factors and presents a moderate market opportunity as a niche area in need of better treatments.
Pulmonary Arterial Hypertension (PAH),57,Respiratory,3.0,Pulmonary Arterial Hypertension (PAH) is a rare disorder with moderate complexity affecting the lungs and often involving inflammation or fibrosis and presents a moderate market opportunity as a niche area in need of better treatments.
Hypertrophic Cardiomyopathy,49,Cardiovascular,2.0,Hypertrophic Cardiomyopathy is a disease with moderate complexity involving multiple organ systems and risk factors and presents a moderate market opportunity as a niche area in need of better treatments.
Transthyretin Amyloid Cardiomyopathy,59,Cardiovascular,2.0,Transthyretin Amyloid Cardiomyopathy is a disease with moderate complexity involving multiple organ systems and risk factors and presents a moderate market opportunity as a niche area in need of better treatments.
Type 1 Diabetes,60,Diabetes,5.0,Type 1 Diabetes is a common condition that is highly complex with complex metabolic dysregulation and has a substantial market opportunity given the number of patients affected.
Type 2 Diabetes,54,Diabetes,30.0,Type 2 Diabetes is a very common condition that is moderately complex with complex metabolic dysregulation and has a very large market potential due to its high prevalence and unmet needs.
Gestational Diabetes,53,Diabetes,2.0,Gestational Diabetes is a common condition with moderate complexity with complex metabolic dysregulation and presents a moderate market opportunity as a niche area in need of better treatments.
Rheumatoid Arthritis,67,Autoimmune,12.0,Rheumatoid Arthritis is a common condition that is highly complex driven by a dysregulated immune system and has a very large market potential due to its high prevalence and unmet needs.
Systemic Lupus Erythematosus,80,Autoimmune,5.0,Systemic Lupus Erythematosus is a common condition that is extremely complex driven by a dysregulated immune system and has a substantial market opportunity given the number of patients affected.
Multiple Sclerosis,58,Autoimmune,8.0,Multiple Sclerosis is a common condition with moderate complexity driven by a dysregulated immune system and has a substantial market opportunity given the number of patients affected.
Psoriasis,78,Autoimmune,8.0,Psoriasis is a common condition that is highly complex driven by a dysregulated immune system and has a substantial market opportunity given the number of patients affected.
Crohn's Disease,63,Autoimmune,8.0,Crohn's Disease is a common condition that is highly complex driven by a dysregulated immune system and has a substantial market opportunity given the number of patients affected.
Ulcerative Colitis,69,Autoimmune,8.0,Ulcerative Colitis is a common condition that is highly complex driven by a dysregulated immune system and has a substantial market opportunity given the number of patients affected.
Ankylosing Spondylitis,69,Autoimmune,3.0,Ankylosing Spondylitis is a disease that is highly complex driven by a dysregulated immune system and presents a moderate market opportunity as a niche area in need of better treatments.
Psoriatic Arthritis,75,Autoimmune,5.0,Psoriatic Arthritis is a disease that is highly complex driven by a dysregulated immune system and has a substantial market opportunity given the number of patients affected.
Sjögren's Syndrome,66,Autoimmune,0.5,Sjögren's Syndrome is a rare disorder that is highly complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Myasthenia Gravis,71,Autoimmune,1.0,Myasthenia Gravis is a rare disorder that is highly complex driven by a dysregulated immune system and presents a moderate market opportunity as a niche area in need of better treatments.
Celiac Disease,47,Autoimmune,2.0,Celiac Disease is a common condition with moderate complexity driven by a dysregulated immune system and presents a moderate market opportunity as a niche area in need of better treatments.
Vitiligo,55,Autoimmune,1.0,Vitiligo is a disease with moderate complexity driven by a dysregulated immune system and presents a moderate market opportunity as a niche area in need of better treatments.
Alopecia Areata,52,Autoimmune,1.0,Alopecia Areata is a disease with moderate complexity driven by a dysregulated immune system and presents a moderate market opportunity as a niche area in need of better treatments.
Sarcoidosis,61,Autoimmune,0.5,Sarcoidosis is a rare disorder that is highly complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Systemic Sclerosis,64,Autoimmune,3.0,Systemic Sclerosis is a rare disorder that is highly complex driven by a dysregulated immune system and presents a moderate market opportunity as a niche area in need of better treatments.
Autoimmune Hepatitis,50,Autoimmune,0.5,Autoimmune Hepatitis is a rare disorder with moderate complexity driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Immune Thrombocytopenic Purpura (ITP),62,Autoimmune,0.5,Immune Thrombocytopenic Purpura (ITP) is a rare disorder that is highly complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Pemphigus Vulgaris,59,Autoimmune,0.3,Pemphigus Vulgaris is a rare disorder with moderate complexity driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Dermatomyositis,80,Autoimmune,0.5,Dermatomyositis is a rare disorder that is extremely complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
ANCA-Associated Vasculitis,78,Autoimmune,0.5,ANCA-Associated Vasculitis is a rare disorder that is extremely complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Juvenile Idiopathic Arthritis (JIA),66,Autoimmune,2.0,Juvenile Idiopathic Arthritis (JIA) is a disease that is highly complex driven by a dysregulated immune system and presents a moderate market opportunity as a niche area in need of better treatments.
Graves' Disease,47,Autoimmune,0.5,Graves' Disease is a disease with moderate complexity driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Hashimoto's Thyroiditis,50,Autoimmune,0.5,Hashimoto's Thyroiditis is a disease with moderate complexity driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Behçet's Disease,63,Autoimmune,0.5,Behçet's Disease is a rare disorder that is highly complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Primary Biliary Cholangitis (PBC),51,Autoimmune,0.5,Primary Biliary Cholangitis (PBC) is a rare disorder with moderate complexity driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
IgA Nephropathy,67,Autoimmune,0.5,IgA Nephropathy is a rare disorder that is highly complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Giant Cell Arteritis,79,Autoimmune,0.5,Giant Cell Arteritis is a rare disorder that is extremely complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Neuromyelitis Optica (NMO),81,Autoimmune,0.5,"Neuromyelitis Optica (NMO) is a rare disorder that is extremely complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need."
Uveitis (non-infectious),62,Autoimmune,0.5,Uveitis (non-infectious) is a rare disorder that is highly complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Cold Agglutinin Disease,83,Autoimmune,0.3,"Cold Agglutinin Disease is a rare disorder that is extremely complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need."
Guillain-Barré Syndrome (GBS),67,Autoimmune,0.5,Guillain-Barré Syndrome (GBS) is a rare disorder that is highly complex driven by a dysregulated immune system and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
HIV/AIDS,78,Infectious,12.0,HIV/AIDS is a very common condition that is highly complex involving host-pathogen interactions and has a very large market potential due to its high prevalence and unmet needs.
Tuberculosis,59,Infectious,1.0,Tuberculosis is a very common condition with moderate complexity involving host-pathogen interactions and presents a moderate market opportunity as a niche area in need of better treatments.
Malaria,68,Infectious,0.5,Malaria is a very common condition that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Influenza,65,Infectious,2.0,Influenza is a very common condition that is highly complex involving host-pathogen interactions and has a very large market potential due to its high prevalence and unmet needs.
COVID-19,81,Infectious,15.0,COVID-19 is a very common condition that is extremely complex involving host-pathogen interactions and has a very large market potential due to its high prevalence and unmet needs.
Hepatitis B,76,Infectious,5.0,Hepatitis B is a very common condition that is extremely complex involving host-pathogen interactions and has a substantial market opportunity given the number of patients affected.
Hepatitis C,52,Infectious,4.0,Hepatitis C is a common condition with moderate complexity involving host-pathogen interactions and has a substantial market opportunity given the number of patients affected.
Respiratory Syncytial Virus (RSV),50,Infectious,1.0,Respiratory Syncytial Virus (RSV) is a common condition with moderate complexity involving host-pathogen interactions and presents a moderate market opportunity as a niche area in need of better treatments.
Ebola Virus Disease,66,Infectious,0.1,Ebola Virus Disease is a rare disorder that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Dengue Fever,65,Infectious,0.5,Dengue Fever is a very common condition that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
MRSA Infection,58,Infectious,1.0,MRSA Infection is a disease with moderate complexity involving host-pathogen interactions and presents a moderate market opportunity as a niche area in need of better treatments.
Drug-resistant Gonorrhea,79,Infectious,0.2,Drug-resistant Gonorrhea is a rare disorder that is extremely complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Sepsis,84,Infectious,3.0,Sepsis is a common condition that is extremely complex involving host-pathogen interactions and has a substantial market opportunity given the number of patients affected.
Clostridioides difficile Infection,63,Infectious,0.5,Clostridioides difficile Infection is a common condition that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Chagas Disease,49,Infectious,0.1,Chagas Disease is a rare disorder with moderate complexity involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Leishmaniasis,56,Infectious,0.1,Leishmaniasis is a rare disorder with moderate complexity involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Schistosomiasis,66,Infectious,0.1,Schistosomiasis is a rare disorder that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
African Trypanosomiasis (Sleeping Sickness),48,Infectious,0.1,African Trypanosomiasis (Sleeping Sickness) is a rare disorder with moderate complexity involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Onchocerciasis (River Blindness),62,Infectious,0.1,Onchocerciasis (River Blindness) is a rare disorder that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Cytomegalovirus (CMV) Infection,66,Infectious,0.5,Cytomegalovirus (CMV) Infection is a disease that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Monkeypox,65,Infectious,0.2,Monkeypox is a rare disorder that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Nontuberculous Mycobacterial Infection (NTM),79,Infectious,0.3,Nontuberculous Mycobacterial Infection (NTM) is a rare disorder that is extremely complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Lyme Disease,49,Infectious,0.3,Lyme Disease is a disease with moderate complexity involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
West Nile Virus Infection,68,Infectious,0.1,West Nile Virus Infection is a rare disorder that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Nipah Virus Infection,69,Infectious,0.1,Nipah Virus Infection is a rare disorder that is highly complex involving host-pathogen interactions and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Alzheimer's Disease,93,Neurological/Psych,20.0,Alzheimer's Disease is a very common condition that is extremely complex involving complex brain and nervous system pathways and has a very large market potential due to its high prevalence and unmet needs.
Parkinson's Disease,77,Neurological/Psych,10.0,Parkinson's Disease is a common condition that is highly complex involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Amyotrophic Lateral Sclerosis (ALS),90,Neurological/Psych,3.0,Amyotrophic Lateral Sclerosis (ALS) is a rare disorder that is extremely complex involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Huntington's Disease,72,Neurological/Psych,2.0,Huntington's Disease is a rare disorder that is highly complex involving complex brain and nervous system pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Epilepsy,56,Neurological/Psych,2.0,Epilepsy is a common condition with moderate complexity involving complex brain and nervous system pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Spinal Cord Injury,79,Neurological/Psych,1.0,Spinal Cord Injury is a disease that is extremely complex involving complex brain and nervous system pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Major Depressive Disorder,64,Neurological/Psych,10.0,Major Depressive Disorder is a very common condition that is highly complex involving complex brain and nervous system pathways and has a very large market potential due to its high prevalence and unmet needs.
Bipolar Disorder,66,Neurological/Psych,4.0,Bipolar Disorder is a common condition that is highly complex involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Schizophrenia,63,Neurological/Psych,8.0,Schizophrenia is a common condition that is highly complex involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Generalized Anxiety Disorder,68,Neurological/Psych,4.0,Generalized Anxiety Disorder is a common condition that is highly complex involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Post-Traumatic Stress Disorder (PTSD),56,Neurological/Psych,3.0,Post-Traumatic Stress Disorder (PTSD) is a common condition with moderate complexity involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Autism Spectrum Disorder,68,Neurological/Psych,5.0,Autism Spectrum Disorder is a common condition that is highly complex involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Attention-Deficit/Hyperactivity Disorder (ADHD),50,Neurological/Psych,5.0,Attention-Deficit/Hyperactivity Disorder (ADHD) is a common condition with moderate complexity involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Frontotemporal Dementia,79,Neurological/Psych,2.0,Frontotemporal Dementia is a rare disorder that is extremely complex involving complex brain and nervous system pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Lewy Body Dementia,65,Neurological/Psych,2.0,Lewy Body Dementia is a rare disorder that is highly complex involving complex brain and nervous system pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Chronic Insomnia,67,Neurological/Psych,2.0,Chronic Insomnia is a common condition that is highly complex involving complex brain and nervous system pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Narcolepsy,64,Neurological/Psych,2.0,Narcolepsy is a rare disorder that is highly complex involving complex brain and nervous system pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Tourette Syndrome,71,Neurological/Psych,0.5,Tourette Syndrome is a rare disorder that is highly complex involving complex brain and nervous system pathways and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Obsessive-Compulsive Disorder (OCD),80,Neurological/Psych,0.5,Obsessive-Compulsive Disorder (OCD) is a disease that is extremely complex involving complex brain and nervous system pathways and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Anorexia Nervosa,60,Neurological/Psych,0.5,Anorexia Nervosa is a disease with moderate complexity involving complex brain and nervous system pathways and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Opioid Use Disorder,70,Neurological/Psych,5.0,Opioid Use Disorder is a common condition that is highly complex involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Alcohol Use Disorder,76,Neurological/Psych,5.0,Alcohol Use Disorder is a common condition that is extremely complex involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Stimulant Use Disorder,66,Neurological/Psych,3.0,Stimulant Use Disorder is a common condition that is highly complex involving complex brain and nervous system pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Nicotine Dependence,60,Neurological/Psych,5.0,Nicotine Dependence is a very common condition with moderate complexity involving complex brain and nervous system pathways and has a substantial market opportunity given the number of patients affected.
Binge Eating Disorder,57,Neurological/Psych,1.0,Binge Eating Disorder is a disease with moderate complexity involving complex brain and nervous system pathways and presents a moderate market opportunity as a niche area in need of better treatments.
Bulimia Nervosa,47,Neurological/Psych,0.5,Bulimia Nervosa is a disease with moderate complexity involving complex brain and nervous system pathways and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Spinocerebellar Ataxia,63,Neurological/Psych,0.5,Spinocerebellar Ataxia is a rare disorder that is highly complex involving complex brain and nervous system pathways and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Hemophilia A,35,Gene Therapy,2.0,Hemophilia A is an inherited blood disorder with relatively straightforward pathology caused by a single genetic defect, making it relatively straightforward at the molecular level and presents a moderate market opportunity as a niche area in need of better treatments.
Hemophilia B,28,Gene Therapy,1.5,Hemophilia B is an inherited blood disorder with relatively straightforward pathology caused by a single genetic defect, making it relatively straightforward at the molecular level and presents a moderate market opportunity as a niche area in need of better treatments.
Sickle Cell Disease,50,Gene Therapy,3.0,Sickle Cell Disease is an inherited blood disorder with moderate complexity caused by a single genetic defect, making it relatively straightforward at the molecular level and has a substantial market opportunity given the number of patients affected.
Beta Thalassemia,35,Gene Therapy,2.0,Beta Thalassemia is an inherited blood disorder with relatively straightforward pathology caused by a single genetic defect, making it relatively straightforward at the molecular level and presents a moderate market opportunity as a niche area in need of better treatments.
Spinal Muscular Atrophy (SMA),40,Gene Therapy,1.0,Spinal Muscular Atrophy (SMA) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and presents a moderate market opportunity as a niche area in need of better treatments.
Duchenne Muscular Dystrophy (DMD),34,Gene Therapy,1.0,Duchenne Muscular Dystrophy (DMD) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and presents a moderate market opportunity as a niche area in need of better treatments.
Leber Congenital Amaurosis (RPE65 mutation),24,Gene Therapy,0.5,Leber Congenital Amaurosis (RPE65 mutation) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Retinitis Pigmentosa,37,Gene Therapy,0.5,Retinitis Pigmentosa is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Severe Combined Immunodeficiency (SCID),31,Gene Therapy,0.5,Severe Combined Immunodeficiency (SCID) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Friedreich's Ataxia,33,Gene Therapy,0.5,Friedreich's Ataxia is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Fabry Disease,37,Gene Therapy,0.5,Fabry Disease is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Pompe Disease,27,Gene Therapy,0.5,Pompe Disease is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Alpha-1 Antitrypsin Deficiency,35,Gene Therapy,0.5,Alpha-1 Antitrypsin Deficiency is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Hurler Syndrome (MPS I),23,Gene Therapy,0.2,Hurler Syndrome (MPS I) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Hunter Syndrome (MPS II),22,Gene Therapy,0.2,Hunter Syndrome (MPS II) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Metachromatic Leukodystrophy (MLD),37,Gene Therapy,0.1,Metachromatic Leukodystrophy (MLD) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Wiskott-Aldrich Syndrome,36,Gene Therapy,0.1,Wiskott-Aldrich Syndrome is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Phenylketonuria (PKU),33,Gene Therapy,0.5,Phenylketonuria (PKU) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Ornithine Transcarbamylase Deficiency,25,Gene Therapy,0.1,Ornithine Transcarbamylase Deficiency is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Charcot-Marie-Tooth Disease (CMT),38,Gene Therapy,0.5,Charcot-Marie-Tooth Disease (CMT) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Usher Syndrome,41,Gene Therapy,0.5,Usher Syndrome is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Gaucher Disease,28,Gene Therapy,0.5,Gaucher Disease is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Sanfilippo Syndrome (MPS III),34,Gene Therapy,0.1,Sanfilippo Syndrome (MPS III) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Crigler-Najjar Syndrome,33,Gene Therapy,0.1,Crigler-Najjar Syndrome is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Limb-Girdle Muscular Dystrophy (LGMD),50,Gene Therapy,0.5,Limb-Girdle Muscular Dystrophy (LGMD) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Facioscapulohumeral Muscular Dystrophy (FSHD),41,Gene Therapy,0.5,Facioscapulohumeral Muscular Dystrophy (FSHD) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Niemann-Pick Disease Type C,30,Gene Therapy,0.1,Niemann-Pick Disease Type C is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Fanconi Anemia,32,Gene Therapy,0.1,Fanconi Anemia is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Diamond-Blackfan Anemia (DBA),42,Gene Therapy,0.1,Diamond-Blackfan Anemia (DBA) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Maple Syrup Urine Disease (MSUD),38,Gene Therapy,0.1,Maple Syrup Urine Disease (MSUD) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Juvenile Batten Disease (CLN3),36,Gene Therapy,0.1,Juvenile Batten Disease (CLN3) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Epidermolysis Bullosa,39,Gene Therapy,0.5,Epidermolysis Bullosa is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Lysosomal Acid Lipase Deficiency (LAL-D),41,Gene Therapy,0.1,Lysosomal Acid Lipase Deficiency (LAL-D) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Classic Galactosemia,43,Gene Therapy,0.1,Classic Galactosemia is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Maroteaux-Lamy Syndrome (MPS VI),24,Gene Therapy,0.2,Maroteaux-Lamy Syndrome (MPS VI) is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency,21,Gene Therapy,0.1,Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency is a rare genetic disorder caused by a single genetic defect, making it relatively straightforward at the molecular level and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Chronic Obstructive Pulmonary Disease (COPD),49,Respiratory,10.0,Chronic Obstructive Pulmonary Disease (COPD) is a very common condition with moderate complexity affecting the lungs and often involving inflammation or fibrosis and has a very large market potential due to its high prevalence and unmet needs.
Asthma,62,Respiratory,12.0,Asthma is a very common condition that is highly complex affecting the lungs and often involving inflammation or fibrosis and has a very large market potential due to its high prevalence and unmet needs.
Idiopathic Pulmonary Fibrosis (IPF),69,Respiratory,2.0,Idiopathic Pulmonary Fibrosis (IPF) is a disease that is highly complex affecting the lungs and often involving inflammation or fibrosis and presents a moderate market opportunity as a niche area in need of better treatments.
Cystic Fibrosis,59,Respiratory,5.0,Cystic Fibrosis is a rare disorder with moderate complexity affecting the lungs and often involving inflammation or fibrosis and has a substantial market opportunity given the number of patients affected.
Acute Respiratory Distress Syndrome (ARDS),62,Respiratory,1.0,Acute Respiratory Distress Syndrome (ARDS) is a disease that is highly complex affecting the lungs and often involving inflammation or fibrosis and presents a moderate market opportunity as a niche area in need of better treatments.
Refractory Chronic Cough,58,Respiratory,0.5,Refractory Chronic Cough is a disease with moderate complexity affecting the lungs and often involving inflammation or fibrosis and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Non-Cystic Fibrosis Bronchiectasis,52,Respiratory,0.5,Non-Cystic Fibrosis Bronchiectasis is a disease with moderate complexity affecting the lungs and often involving inflammation or fibrosis and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Graft-versus-Host Disease (GVHD),80,Transplant,1.0,Graft-versus-Host Disease (GVHD) is a rare disorder that is extremely complex involving immune rejection processes and presents a moderate market opportunity as a niche area in need of better treatments.
Organ Transplant Rejection,81,Transplant,2.0,Organ Transplant Rejection is a disease that is extremely complex involving immune rejection processes and presents a moderate market opportunity as a niche area in need of better treatments.
Chronic Organ Rejection,73,Transplant,1.0,Chronic Organ Rejection is a disease that is highly complex involving immune rejection processes and presents a moderate market opportunity as a niche area in need of better treatments.
Obesity,72,Other,25.0,Obesity is a very common condition that is highly complex with diverse underlying mechanisms and has a very large market potential due to its high prevalence and unmet needs.
Non-alcoholic Steatohepatitis (NASH),59,Other,15.0,Non-alcoholic Steatohepatitis (NASH) is a very common condition with moderate complexity with diverse underlying mechanisms and has a very large market potential due to its high prevalence and unmet needs.
Chronic Kidney Disease (CKD),65,Other,10.0,Chronic Kidney Disease (CKD) is a very common condition that is highly complex with diverse underlying mechanisms and has a very large market potential due to its high prevalence and unmet needs.
Polycystic Kidney Disease (PKD),57,Other,1.0,Polycystic Kidney Disease (PKD) is a rare disorder with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Osteoporosis,58,Other,5.0,Osteoporosis is a very common condition with moderate complexity with diverse underlying mechanisms and has a substantial market opportunity given the number of patients affected.
Atopic Dermatitis (Eczema),66,Other,10.0,Atopic Dermatitis (Eczema) is a very common condition that is highly complex with diverse underlying mechanisms and has a very large market potential due to its high prevalence and unmet needs.
Irritable Bowel Syndrome (IBS),43,Other,3.0,Irritable Bowel Syndrome (IBS) is a common condition with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Polycystic Ovary Syndrome (PCOS),42,Other,2.0,Polycystic Ovary Syndrome (PCOS) is a common condition with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Uterine Fibroids,41,Other,2.0,Uterine Fibroids is a common condition with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Age-related Macular Degeneration (AMD),79,Other,10.0,Age-related Macular Degeneration (AMD) is a very common condition that is extremely complex with diverse underlying mechanisms and has a very large market potential due to its high prevalence and unmet needs.
Diabetic Retinopathy,60,Other,5.0,Diabetic Retinopathy is a common condition that is highly complex with diverse underlying mechanisms and has a substantial market opportunity given the number of patients affected.
Glaucoma,62,Other,3.0,Glaucoma is a common condition that is highly complex with diverse underlying mechanisms and has a substantial market opportunity given the number of patients affected.
Hearing Loss,76,Other,8.0,Hearing Loss is a very common condition that is extremely complex with diverse underlying mechanisms and has a substantial market opportunity given the number of patients affected.
Primary Sclerosing Cholangitis (PSC),62,Other,0.5,Primary Sclerosing Cholangitis (PSC) is a rare disorder that is highly complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Congenital Adrenal Hyperplasia (CAH),52,Other,0.5,Congenital Adrenal Hyperplasia (CAH) is a rare disorder with moderate complexity with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Chronic Fatigue Syndrome (ME/CFS),64,Other,0.5,Chronic Fatigue Syndrome (ME/CFS) is a rare disorder that is highly complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Post-COVID Syndrome (Long COVID),63,Other,1.0,Post-COVID Syndrome (Long COVID) is a disease that is highly complex with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Hereditary Angioedema (HAE),67,Other,0.5,Hereditary Angioedema (HAE) is a rare disorder that is highly complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Food Allergy (e.g. Peanut Allergy),55,Other,1.0,Food Allergy (e.g. Peanut Allergy) is a common condition with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Acne,63,Other,2.0,Acne is a very common condition that is highly complex with diverse underlying mechanisms and has a substantial market opportunity given the number of patients affected.
Rosacea,60,Other,1.0,Rosacea is a common condition that is highly complex with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Hidradenitis Suppurativa,62,Other,1.0,Hidradenitis Suppurativa is a rare disorder that is highly complex with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Gastroparesis,70,Other,0.5,Gastroparesis is a rare disorder that is highly complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Short Bowel Syndrome,66,Other,0.3,Short Bowel Syndrome is a rare disorder that is highly complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Chronic Idiopathic Constipation,58,Other,1.0,Chronic Idiopathic Constipation is a common condition with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Paroxysmal Nocturnal Hemoglobinuria (PNH),78,Other,0.5,Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare disorder that is extremely complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Fibrodysplasia Ossificans Progressiva (FOP),76,Other,0.2,Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that is extremely complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Benign Prostatic Hyperplasia (BPH),55,Other,2.0,Benign Prostatic Hyperplasia (BPH) is a very common condition with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Overactive Bladder,45,Other,2.0,Overactive Bladder is a very common condition with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Focal Segmental Glomerulosclerosis (FSGS),64,Other,0.5,Focal Segmental Glomerulosclerosis (FSGS) is a rare disorder that is highly complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Systemic Mastocytosis,72,Other,0.5,Systemic Mastocytosis is a rare disorder that is extremely complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Hypoparathyroidism,64,Other,0.5,Hypoparathyroidism is a rare disorder that is highly complex with diverse underlying mechanisms and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
Dry Eye Disease,53,Other,2.0,Dry Eye Disease is a common condition with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Male Contraception,51,Other,1.0,Male Contraception is a disease with moderate complexity with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Female Infertility,67,Other,1.0,Female Infertility is a disease that is highly complex with diverse underlying mechanisms and presents a moderate market opportunity as a niche area in need of better treatments.
Von Willebrand Disease,38,Other,0.5,Von Willebrand Disease is a rare disorder with relatively straightforward underlying biology and represents a niche market because of its rarity, though addressing it would fulfill an important unmet need.
